Stocks move premarket after earnings, trial results, and guidance updates
Premarket trading moves: Replimune, Chevron, Amazon and Apple react to results See which earnings, trial updates and forecasts are driving Friday's biggest stock swings
Several large companies moved sharply in premarket trading Friday after earnings reports, drugtrial updates, and other corporate news.
Replimune surged after an FDA advisory panel backed the company’s RP1 trial results for a skin cancer treatment, while Wedbush raised its rating on the biotech firm. Chevron edged higher after reporting secondquarter results that topped expectations, while ExxonMobil fell after missing on earnings.
Among other notable movers, Amazon climbed after posting strongerthanexpected revenue and cloud growth, while Apple declined despite betterthanexpected revenue because of market reaction to its latest quarter. Moderna, Coinbase, Reddit, and Novo Nordisk also traded lower after their respective results or trial updates.